Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
[1] [4] For weight management, Zepbound is indicated for adults with a BMI 30 kg/m or 27 kg/m with at least one weight-related comorbidity
Clinical evidence suggests tirzepatide produces weight loss approximately 15 to 20 percent faster than semaglutide at comparable timepoints, likely due to its dual GIP/GLP-1 mechanism
95% CI, 1.11 to 2.78)
Wegovy and Ozempic are brand names for a type of GLP-1 receptor agonist known as semaglutide
Zepbound is simply the FDA-approved brand-name version of tirzepatide, manufactured by Eli Lilly
In the UK the drugs are only available with permission from a medical doctor, who will issue a prescription only if the patient satisfies the rigorous eligibility criteria
US$ 27.54
US$ 23.48
US$ 24.01
US$ 28.62
